HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)
暂无分享,去创建一个
J. Phair | A. Muñoz | C. Thio | R. Skolasky | B. Visscher | J. Phair | E. Seaberg | David L. Thomas | D. Thomas | D. Thomas
[1] J. Margolick,et al. Immunologic and virologic response to highly active antiretroviral therapy in the Multicenter AIDS Cohort Study , 2001, AIDS.
[2] J. Margolick,et al. Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis , 2001, AIDS.
[3] D. Snydman,et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] P. Reiss,et al. Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection , 2000, AIDS.
[5] R. Greenblatt,et al. Selection by indication of potent antiretroviral therapy use in a large cohort of women infected with human immunodeficiency virus. , 2000, American journal of epidemiology.
[6] D. Vergani,et al. Incubation phase of acute hepatitis B in man: Dynamic of cellular immune mechanisms , 2000, Hepatology.
[7] M. Stoll,et al. Immune reconstitution syndromes in human immuno-deficiency virus infection following effective antiretroviral therapy. , 2000, Immunobiology.
[8] F. Donato,et al. Mortality for liver disease in patients with HIV infection: a cohort study. , 2000, Journal of acquired immune deficiency syndromes.
[9] M. Lindegren,et al. Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] R. Chaisson,et al. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. , 2000, JAMA.
[11] C. Katlama,et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients , 1999, Hepatology.
[12] H. Margolis,et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. , 1999, The New England journal of medicine.
[13] S. Lawrence,et al. Chronic active hepatitis B exacerbations in human immunodeficiency virus-infected patients following development of resistance to or withdrawal of lamivudine. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] M. Loriot,et al. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men , 1999, Hepatology.
[15] B. Yip,et al. The incidence and spectrum of AIDS-defining illnesses in persons treated with antiretroviral drugs. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] V. Vullo,et al. Acute clinical hepatitis in an HIV-seropositive hepatitis B carrier receiving protease inhibitor therapy. , 1998, AIDS.
[17] S. Darby,et al. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C , 1997, The Lancet.
[18] C. J. Chen,et al. Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. , 1997, American journal of epidemiology.
[19] D. Cooper,et al. Restoration of immunity to chronic hepatitis B infection in HIV-infected patient on protease inhibitor , 1997, The Lancet.
[20] R. Tedder,et al. Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection , 1997, AIDS.
[21] K. O'rourke,et al. The interaction of human immunodeficiency virus infection and hepatitis B virus infection in infected homosexual men. , 1996, Journal of clinical gastroenterology.
[22] London Wt,et al. The epidemiology of hepatitis viruses B, C, and D. , 1996 .
[23] M. Alter,et al. Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases. , 1994, The Journal of infectious diseases.
[24] J. Villeneuve,et al. A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal. , 1994, Gastroenterology.
[25] G. Beebe,et al. Mortality follow‐up of the 1942 epidemic of hepatitis B in the U.S. Army , 1993, Hepatology.
[26] D. Vlahov,et al. Antibody to hepatitis C virus among cardiac surgery patients, homosexual men, and intravenous drug users in Baltimore, Maryland. , 1991, American journal of epidemiology.
[27] S. Hadler,et al. Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection. , 1991, The Journal of infectious diseases.
[28] R. Perrillo,et al. Relationship between histology, aminotransferase levels, and viral replication in chronic hepatitis B. , 1990, Gastroenterology.
[29] B. McMahon,et al. Hepatitis B-related sequelae. Prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers. , 1990, Archives of internal medicine.
[30] R. Palmiter,et al. Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. , 1990, Science.
[31] B. Donovan,et al. The effect of concurrent human immunodeficiency virus infection on chronic hepatitis B: a study of 150 homosexual men. , 1989, The Journal of infectious diseases.
[32] C. Horsburgh,et al. Hepatic inflammation, hepatitis B replication, and cellular immune function in homosexual males with chronic hepatitis B and antibody to human immunodeficiency virus. , 1988, The American journal of gastroenterology.
[33] R. Brookmeyer,et al. Factors associated with prevalent human immunodeficiency virus (HIV) infection in the Multicenter AIDS Cohort Study. , 1987, American journal of epidemiology.
[34] J. Phair,et al. The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. , 1987, American journal of epidemiology.
[35] E. Schiff,et al. A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army. , 1987, The New England journal of medicine.
[36] A. Zuckerman,et al. FULMINANT HEPATIC FAILURE IN LEUKAEMIA AND CHORIOCARCINOMA RELATED TO WITHDRAWAL OF CYTOTOXIC DRUG THERAPY , 1975, The Lancet.
[37] A. Skulberg,et al. Letter: Occupational hazard of halothane. , 1974, Lancet.
[38] F. Callea,et al. Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus. , 2001, The Journal of infectious diseases.
[39] Clive Osmond,et al. Statistical Methods in Cancer Research, Vol. 2, the Design and Analysis of Cohort Studies , 1990 .
[40] N. Breslow,et al. Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. , 1987, IARC scientific publications.